CRPS I Complex Regional Pain Syndrome Type I Sympathetic Reflex Dystrophy Pain Exposure Physical Therapy Pharmacological treatment Functional recovery Posttraumatische Dystrofie
Conditions
Interventions
Treatment group: In the treatment group medication prescribed for CRPS is tapered to zero. No invasive treatments like sympathetic blocks, and/or operations will be performed. After information about
Sponsors
Radboud University Nijmegen Medical Centre, The Netherlands
Dpt. of Surgery
Eligibility
Inclusion criteria
Inclusion criteria: Patients between 18 and 80 years of age with Complex Regional pain Syndrome (CRPS-1) of either upper or lower extremity according to Bruehl's/IASP criteria between 3 and 24 months after initial injury will be selected for the study.
Exclusion criteria
Exclusion criteria: Patients who do not comply with the inclusion criteria, especially those who have other causes that may explain a pain syndrome will be excluded (IASP criterium).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measure is the Impairment level SumScore (ISS), which consists of three measurement parameters (pain, active range of motion and temperature) and four measurement instruments (VAS, McGill Pain Questionnaire, goniometry of mobility of joints and skin thermometer). | — |
Secondary
| Measure | Time frame |
|---|---|
| A cost-effectiveness analysis from a societal perspective comparing PEPT to usual care in patients with CRPS will be performed. This will be done along-side the clinical trial. | — |
Contacts
Public ContactTj. Tromp
Outcome results
None listed